Stocks To Buy Now Blog

All posts by Christopher

FinovateFall 2022-New York To Host Global Fintech Experts

FinovateFall 2022 is being held this year at The Marriott Marquis Times Square, New York. The list of attendees includes fintech companies and startups, the top 10 banks in the US, and 275+ fintech institutions. Participants also include professionals from financial institutions, fintech institutes, regulators, banking institutions, companies, analysts, and investors. This is a wonderful opportunity for fintech startups and companies to foster important connections, to learn and significantly expand their prospects. The event showcases 60+ innovative demos, 100 + expert speakers, and 1500 + influential attendees (50%+ from financial institutions). The fintech experts presiding over the sessions will interact with the audience and address their concerns. They will discuss the different aspects of the fintech ecosystem covering prospects, hurdles, and solutions. Get the latest insights and strategies from the experts during formal panels, discussions, keynotes, and meetings. The experts will cover a range of topics over the entire fintech spectrum, covering the length and breadth of fintech issues. Attendees can participate in the networking sessions or watch the exciting and punchy live demos by hand-selected startups and young fintech experts who will showcase their services in easy-to-follow summary presentations. Also get expert insights from fintech influencers, all under one roof. Connect with your favorite speakers to get specific advice for all spheres of the fintech ecosystem, investments, and other future concerns. You can also check out the sustainable fintech scholarship program, new for 2022. There have been phenomenal changes in the way the fintech ecosystem operates due to Covid-19. Attendees will understand how financial services have been affected and how the pandemic has accelerated innovation and the adoption of new technologies. The sessions provide a fresh perspective into how these unprecedented times will shape the future. The mastermind keynote session will be delivered by Chris Cox, CEO, Apiture. The discussion will focus on the topic-Closing the Data Intelligence Gap. The discussion will include insights on how financial institutions can better process and analyze available data such that it is helpful to their business and their customers while also maintaining regulatory compliance. Additional mastermind keynote sessions will follow. The attendees have access to the content on-demand for 12 months after the event with sessions available to access online a week after the event runs. To learn more, please visit https://ibn.fm/PX5z9.

GeoSolar Technologies Inc.’s SmartGreen(TM) Tech Transforms Homes, Enables Energy Independence

  • GeoSolar goes beyond solar panel installation to provide complete home energy makeovers that can eliminate utility bills, provide energy independence
  • GeoSolar’s SmartGreen(TM) technology produces energy through rooftop photovoltaic (“PV”) solar systems and geothermal ground loops
  • Additional system customizations include tightening building envelope, insulation upgrades, LED lighting replacement, and EV charging infrastructure
  • SEC recently qualified GeoSolar for Regulation A+ capital raise
GeoSolar Technologies (“GST”), a Colorado-based climate technology company, goes beyond solar panel installation to provide complete building “green energy” makeovers that redefine power generation, utility, and conservation. GeoSolar’s SmartGreen(TM) energy technology leverages the power of the earth and sun to heat, cool, power, and purify newly built and existing homes. A SmartGreen(TM) building produces energy in two ways: rooftop photovoltaic (“PV”) solar systems generate electricity year-round, and geothermal ground loops use the earth as a heat source or heat sink depending on the home’s heating and cooling needs. SmartGreen(TM) enables total building makeovers, giving home and business owners energy independence at a critical time. Heating and cooling account for over half the energy required in a typical building, leading to rising costs during inflationary periods when economic conditions are unstable. SmartGreen(TM) counteracts price inflation by leveraging stable, constant renewable alternatives to fossil fuel-based energy sources that contribute to air pollution, environmental damage, and political instability throughout the world. Fossil fuels such as natural gas, coal, and oil have a finite supply that experts predict will be exhausted by 2150. Conversely, the earth constantly generates energy by absorbing 44% of the sun’s rays and storing that power like a battery (https://ibn.fm/FPnuG). This safe, renewable, and unlimited energy source is at the heart of GeoSolar’s SmartGreen(TM) system, accessed by drilling wells 300-400 feet below the earth, and inserting high-density polyethylene pipe ground loops that extract power and disperse it throughout the home (https://ibn.fm/sjLaa). SmartGreen(TM) is accessible to homeowners and pays for itself through reduced or eliminated utility bills. GeoSolar’s team first analyzes the home for toxic materials such as mold, asbestos, and radon. Next, a project manager assesses site conditions, including envelope insulation, ductwork, radiant floor loops, existing HVAC equipment, rooftop availability for solar panels, electrical infrastructure, lighting systems, and geothermal drilling sites. Energy usage and requirements are then determined to design an optimized system that produces total power requirements to heat and cool the home and power all appliances – including an electric vehicle. Multiple test building installations across Colorado have demonstrated exceptional results and continue to validate the company’s technology. Demand for solar panels alone is skyrocketing due to soaring fuel prices and is expected to surpass $1 trillion by 2028 at a CAGR of 25.9% (https://ibn.fm/wIQbW). With an addressable target market of over 120 million homes across the United States, GeoSolar aims to make SmartGreen(TM) accessible to a wide range of markets across the country. Almost anyone can support a more sustainable future by investing in SmartGreen(TM) technology. GeoSolar was recently qualified by the U.S. Securities and Exchange Commission to conduct a Regulation A+ capital raise, allowing investors to buy in for as little as $300 (https://ibn.fm/8riFK). For more information on GeoSolar’s Regulation A+ capital raise, please visit https://www.manhattanstreetcapital.com/geosolar-technologies-inc. For more information, visit the company’s website at www.GeoSolarPlus.com. NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA) Seeks to Address Electric Vehicle Energy Efficiency Issues Through Proprietary Powertrain Solution

  • Electric vehicle charging infrastructure can be notorious for its efficiency losses, with onboard car chargers habitually losing 14% or more of the energy put into the vehicle
  • Hillcrest Energy Technologies has looked to address that issue through the release of their simplified EV charger solution
  • The traction inverter market is projected to reach $7 billion by 2025 at a CAGR of 17.57% due to increased demand for EV’s
Electric vehicle (“EV”) owners are currently living through a scenario not entirely dissimilar to that being borne by their internal combustion engine vehicle driving counterparts. Over the past year, several car-charging operations have shifted away from EV owners paying per charging session, rather opting to have customer pay per kWh of energy input. However, and unlike gasoline-powered vehicles, paying per unit of electric power for an EV can be confounding. In one test, an EV using a commercial charging point was revealed to be taking on 27.83 kW – despite the battery pack of the vehicle boasting a total capacity of 27 kWh and still possessing a slight level of charge (https://ibn.fm/34S25). The key difference comes down to efficiency losses, a paradigm which Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F), a clean technology company developing transformative power conversion technologies, seeks to address. According to Korean automaker Kia, it is typical for an electric vehicle’s onboard charger to lose 14 percent or more of the energy inputted on the way to the battery pack’s cells. Furthermore, electric vehicles equipped for 800V architecture – are habitually obliged to carry an onboard booster unit to make them compatible with traditional 400V chargers. Extra equipment in an EV, such as the booster, adds weight and cost – both factors that impact range and affordability of an EV. Hillcrest Energy Technologies has sought to resolve these issues and more through their proprietary and simplified EV charging solution. The company recently filed a patent for its enhanced powertrain solution,  a bidirectional charging architecture that leverages the efficiency and high switching frequency capabilities of the company’s high-efficiency traction inverter to simplify the overall powertrain system and enhance an EV’s performance and capabilities beyond what is currently available. With this solution, EVs would no longer require an onboard charger or booster, which is expected to improve the input power efficiency and reduce the cost, complexity, and weight of an EV powertrain. Elimination of the onboard charger would also allow an EV to be AC-charged with the maximum power capability of the traction inverter or of the AC charging source (whichever is lower) regardless of the system voltage. Additionally, the technology is intended to enable DC fast charging of 800V traction systems on existing 400V chargers without the need for an onboard booster unit. Booster units are typically of a similar size and cost to the EV’s traction inverter. Eliminating the need for this unit as well as the onboard charger goes a long way in improving system efficiency, simplifying an EV and providing meaningful reductions in weight and cost and improvements. Markets and Markets published a report in 2019, confirming expectations that power inverter demand is expected to grow sharply within the next decade (https://ibn.fm/Xh3fU). According to the Traction Inverter Market propulsion analysis, the global traction inverter market is projected to reach $7.7 billion by 2025 due to an influence from stringent emission norms to prevent environmental impact, technological advancements in EV’s, increasing subsidies and tax rebates offered by governments and growing EV production. Hillcrest’s management team leverages decades of experience across multiple energy-focused industries, including clean technologies, progressive policy leadership, electrification technology deployment, and capital markets. With a successful track record that includes a strategic exit from fossil fuels, Hillcrest is favorably positioned to address the unique demands of the growing renewable energy industry. For more information, visit the company’s website at www.HillcrestEnergy.tech. NOTE TO INVESTORS: The latest news and updates relating to HLRTF are available in the company’s newsroom at https://ibn.fm/HLRTF

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces the Availability of a Broadcast titled, “The Power of Science to Stop a Killer”

  • Lexaria’s latest broadcast highlights the company’s progress in finding a potential solution for hypertension treatment while also pointing out why such a solution is much needed at this point
  • Since the company began developing its patented DehydraTECH(TM) technology in 2014, it has made significant progress in its clinical studies, even as it currently focuses on human clinical research to evaluate the tolerability, safety, and efficacy of its solution for hypertension treatment
  • Lexaria expressed its confidence in its proposed solution, noting that it will not only be a safer but also better-tolerated drug candidate, unlike current alternatives in the market whose side effects far outweigh their benefits
  • The company looks to capitalize on the growing global anti-hypertensive drugs market, which is projected to hit $27.81 billion in value by 2025, and maintains that should it sustain the results achieved in recent hypertension studies, then it could be looking at mega-drug status ($1 billion per year) in the hypertension market
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just released its latest addition to a growing body of corporate communication pieces in its line-up. Titled “The Power of Science to Stop a Killer,” this recent broadcast highlights the company’s progress in finding a potential solution for hypertension treatment, while also pointing out why a solution is much needed at this point (https://ibn.fm/Vr2xJ). Lexaria’s flagship offering, its patented DehydraTECH(TM) technology, has proven to improve ways through which active pharmaceutical ingredients (“APIs”) enter the bloodstream, primarily by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. This overall effectiveness has seen the technology’s application in various segments, including but not limited to nicotine replacement, CBD, antivirals, epilepsy, human hormones, and PDE5 inhibitors. Lexaria’s venture into the hypertension sector acknowledges that over 114 million adults in the United States are at risk of damage caused by hypertension. In addition, the condition contributed to over 670,000 deaths within the country in 2020 alone (https://ibn.fm/FfRJX). In this broadcast, Lexaria highlighted the progress it has made in its clinical studies and its success so far, ever since it began developing DehydraTECH in 2014. Furthermore, it expressed its confidence that its proposed solution will not only be safer but also a better-tolerated drug candidate, unlike current alternatives in the market whose side effects far outweigh their benefits. Lexaria has made significant advancements in its clinical processes, amassing a growing body of evidence that strongly supports the use of its technology in hypertension therapeutics. This is not just a relief to millions of patients living with the condition but also a welcome addition for the company’s shareholders. In the communication, Lexaria noted that its valuation looks attractive with arguably significant upside. As a result, it looks to rub shoulders and gain attention from the likes of Pfizer Inc. (NYSE: PFE), Merc & Company Inc. (NYSE: MRK), AstraZeneca PLC (NASDAQ: AZN), and Novartis AG (NYSE: NVS). ReportLinker projects that the global anti-hypertensive drugs market will be valued at $27.81 billion by 2025, up from $24.17 billion in 2020, representing a compound annual growth rate (“CAGR”) of 0.8% (https://ibn.fm/VvUtZ). For comparison, each year, the United States spends an average of $131 billion in hypertension costs, with figures expected to go up, particularly given the low awareness of anti-hypertensive drugs amongst the population. Lexaria is optimistic that with its DehydraTECH technology, hypertension treatment will not only be more accessible but also more efficient and effective, ultimately allowing for a better quality of life for patients and a healthier, more productive population. The company is currently focusing on human clinical studies to evaluate the tolerability, safety, and efficacy of its solution for hypertension treatment. In addition, it is inching closer to approval by the United States Food and Drug Administration (“FDA”), having received positive feedback from the institution on its DehydraTECH-CBD proposals earlier this month (https://ibn.fm/8Mnmx). Lexaria’s management still maintains late 2022/early 2023 for its Investigational New Drug (“IND”) application with the FDA and remains confident that should it sustain the results achieved in recent hypertension studies, then it could be looking at mega-drug status ($1 billion per year) in the hypertension market. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Looking to Fill Glioblastoma Multiforme Treatment Gap with Berubicin Drug Product

  • CNS Pharmaceuticals is currently undertaking a potentially pivotal global study evaluating the efficacy and safety of Berubicin compared with Lomustine administered after first-line therapy for the treatment of recurrent glioblastoma multiforme (“GBM”)
  • GBM is an aggressive form of cancer that occurs in the brain or spinal cord
  • In the U.S., it affects between 12,000-15,000 new patients annually with a median survival rate of only 14.6 months from its diagnosis
  • CNS’s drug development program is targeting the GBM drug market which is expected to expand at a CAGR of more than 4% between 2020 and 2030
On July 24, 2021, pre-clinical stage biotechnology company CNS Pharmaceuticals (NASDAQ: CNSP) received Fast Track Designation from the U.S. Food and Drug Administration (“FDA”) for its Berubicin drug product (https://ibn.fm/fFjF8). Granted to help facilitate the development and expedite the review of drugs being developed to treat serious conditions and fill unmet medical needs, the designation showed the seriousness of Glioblastoma Multiforme (“GBM”), an aggressive form of cancer that occurs in the brain or spinal cord. The Fast Track status came just over a year after the company had received Orphan Drug Designation (“ODD”), which is intended to support the development and review of novel treatments for rare diseases. GBM is considered one of the most complex, deadly, and treatment-resistant cancers. And although it is regarded as a rare condition, between 12,000 and 15,000 Americans are diagnosed with the condition every year. Even more devastatingly, the National Brain Tumor Society (“NBTS”) estimates that over 10,000 individuals with GBM succumb to the disease annually. GBM has a five-year survival rate of only 6.8%, and the average length of survival for patients is estimated to be eight months (https://ibn.fm/NJRpv). Per the NBTS, “survival rates and mortality statistics for GBM have been virtually unchanged for decades,” indicating a treatment gap that CNS intends to fill with its lead product candidate, Berubicin, an innovative anthracycline that appears to cross over the blood-brain barrier and kill tumor cells. Typical treatment modalities include surgery, which aims to remove as much of the tumor as possible, followed by radiation treatment with chemotherapy. However, a recent article in KPRC’s Click2Houston reads, “GBM can be hard to treat as the tumors often penetrate sensitive areas of the brain responsible for vital neurologic processes, meaning it is not often possible to completely remove a GBM tumor with surgery. GBM grows aggressively within the brain and typically causes progressive neurological symptoms over time.” Additionally, chemotherapy treatment, Dr. Tobias Walbert, a neuro-oncologist, told KPRC2+ in an interview, causes side effects such as nausea and fatigue, which overlap GBM’s symptoms (https://ibn.fm/FQ3gQ). Against the backdrop of statistics that show the aggressiveness of GBM, CNS is leading the charge to find a potential treatment option for the disease. “In the results of the first Berubicin clinical trial, 44% of the patients showed a clinical response, with one Durable Complete Response (a demonstrated lack of detectable cancer cells),” CNS’s website reads (https://ibn.fm/IKBmv). “Berubicin has shown evidence of improved survival in a patient population that currently has a dismal median survival rate of only 14.6 months from its diagnosis.” Currently, the company is focusing on an ongoing, potentially pivotal global study that commenced in March last year. The study is investigating the efficacy and safety of Berubicin compared with Lomustine administered after first-line therapy for the treatment of recurrent GBM. Its primary endpoint is Overall Survival, which, as the company’s website explains, is “a rigorous endpoint that the U.S. FDA has recognized as the basis for approval of oncology drugs when a statistically significant improvement can be shown relative to a randomized control arm.” The study’s primary completion date is in October 2024, while its estimated completion date is in February 2025 (https://ibn.fm/VJ0JL). Through its drug development program that includes its potentially pivotal global study, CNS aims to enter the burgeoning GBM global drug market. Analysts at GlobalData PLC estimate that the total sales of GBM treatments, estimated to be $549.1 million in 2020, are set to grow at a CAGR of over 4% between 2020 and 2030 (https://ibn.fm/MoPL3). For more information, visit the company’s website at www.CNSPharma.com. NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP

Strong Earnings, Revenue Reports from Plant-based Foods Maker Belle Pulses, Drives Cheery Assessment for Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF)

  • Plant-based foods investment company Eat Well Investment Group Inc. recently released its Q2 financial report for its Belle Pulses subsidiary, showing record growth in key market segments
  • Belle Pulses’ revenues grew 6.8 percent YOY to $15.17 million
  • The company’s gross profit grew by 59.6 percent to $2 million
  • Belle’s net earnings grew a whopping 295.8 percent YOY to $1.37 million
  • Belle Pulses is 100 percent owned by Eat Well, along with plant-based snack food developer Sapientia
  • Sapientia and Eat Well’s other subsidiary, baby food maker Amara, are poised to increase distribution outlets as their profiles grow
Eat Well Investment Group (CSE: EWG) (OTC: EWGFF), a plant-based foods investment company with an international supply chain, is reporting strategic successes that have boosted its Q2 revenues, gross profits and net earnings to record levels for subsidiary Belle Pulses Ltd. Belle Pulses produces inexpensive, plant-based protein — using peas as a key ingredient in noodles, pastas, ice creams, non-dairy milk, plant-based meats, soups, sauces, crackers, nutrition bars and other baked goods for a number of countries in the developing world as well as in the United States. The proteins serve markets for both human and pet consumers, and the company reported earlier this year that several of Belle Pulses’ major customers had increased their orders with the company. Belle’s revenues for the quarter ended May 31 at nearly $15.2 million, up from $14.2 million for the period a year earlier as COVID’s impact on the economy settled, according to the company’s Aug. 2 news release (https://ibn.fm/ZcmDq). The revenue growth represents a 6.8 percent increase YOY. “Belle Pulses’ performance is exceeding expectations, and we remain very pleased with the growth rate and strong ability to execute from Tony and Francis Gaudet as they continue to lead Belle Pulses,” Eat Well President and CEO Marc Aneed stated. “Food security has become a major concern around the world. From severe weather to disrupted supply chains, and global conflicts … real food, right now, is what the world needs, and that’s what Eat Well’s portfolio companies are supplying every week.” Eat Well’s portfolio companies include Sapientia, which is developing plant-based snacks to supplement the options available to the food industry, and Amara, which has a proprietary IP for plant-based baby and toddler foods. Amara is one of the fastest growing baby food brands in the United States and has doubled its distribution footprint from 28 to 56 clubs while increasing its e-commerce performance 76 percent from Q1 to Q2, according to the company. Sapientia is poised to increase distribution of its products through 350 to 550 new convenience stores in Q3 over the current 350 C-store outlets, and is launching research and development of pet treats and “kid household” snacks. But Belle was the star player during the second quarter, not only increasing revenues but also boosting its gross profits 59.6 percent to a record $2 million and its net earnings by 295.8 percent to a record of nearly $1.4 million. Much of the increase was likely attributable to market pressures from reduced yields resulting from Europe’s international conflict, drought and other climate change effects, and inflationary issues, the company stated. Belle Pulses is distributed in 35 countries and its Saskatchewan base is one of three places in the world where pulses are made, with Ukraine’s under-siege status putting one of the others under a significant threat and political tensions with China creating a potential challenge in the third. “So Belle is fielding calls from around the world,” Aneed said earlier this summer. For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

Friendable Inc. (FDBL) Addresses Churn in the Music Streaming Industry by Offering Fan Pass Live and Branded Products to Enhance Listener Experience

  • Churn occurs when subscribers sign up for a streaming service and immediately cancel once the current season or event is over, but re-sign up when something new catches their attention
  • Fan Pass Live offers subscribers a new type of experience that revolves around the life of their favorite artists and the ability to see them on-demand
  • The global music streaming industry was valued at $29.49 billion in 2021 and is expected to reach $103.07 billion by 2030, growing at a CAGR of 14.7%
For companies competing in the music and video streaming industry, personalization is becoming a key contributor to earning higher subscriber retention rates. Churn has always been a problem in the landscape, with subscribers signing up for subscription services but leaving the platforms once their need was fulfilled and signing up again when a new season or event occurs. With video streaming platforms introducing algorithms that “recommend” what you should watch next, Friendable (OTC: FDBL), a mobile technology company focused on its Fan Pass Live artist platform, is introducing a new way to engage and retain subscribers through its Fan Pass Live branded offering. The Fan Pass Live artist platform proactively supports artists and provides a personalized experience for fans who subscribe to its music platform, including:
  • An exclusive look into the artists’ lives
  • The ability to browse for upcoming events (online and in-person)
  • Backstage access before, during, and after an event
  • A single dashboard where fans can view notifications, discussions, and new artists
  • Real-time interactions through livestream performances
  • Exclusive interviews and one-on-one videos
  • A behind-the-scenes look at music videos and photoshoots
  • Access to exclusive artist merchandise
For $2.99 per month, fans gain access to a growing catalog of artists across multiple musical genres, including pop, rock, indie, jazz, and more. Additional charges apply for VIP and Pay-Per-View performances, with artists earning 100% revenue from ticket sales and fan tips. Yearly rates are also available for fans subscribing to the music platform, offering a discount from the monthly price. At the beginning of 2022, Friendable announced the successful acquisition of Artist Republik and FeaturedX, completing its offering as a 360-degree offering for artists and adding additional opportunities for fans. Now, artists can produce, distribute, and market their music across additional platforms, in addition to creating musical collaborations with other artists with ease. The current artist contest being held by the company is the Artist Republik Song of the Summer contest. All entries have been submitted and narrowed down. Although the artists are in control of their music, fan voting controls the winner of the $1,000 prize in each genre category. In the coming months, Fan Pass Live’s artist platform will offer artists and fans the opportunity to experience music in a new realm – with NFTs and Metaverse performances. As the digital landscape of music evolves, Friendable is at the forefront of bringing new technology to the music industry. The global music streaming market size reached $29.49 billion in 2021 and is expected to grow at a CAGR of 14.7%, resulting in $103.07 billion by 2030. The industry’s growth is expected to occur due to the increased interest in digital platforms and the use of smart devices, which enhance the experience for artists and fans alike. Despite the churn that occurs for subscription services, platforms are still popular for their ability to personalize the music experience and the ease of use for connectivity, allowing for hassle-free apps and browser experiences (https://ibn.fm/Sh6we). Fan Pass Live personalizes the music experience for the fans by taking them on a journey with their favorite artists through the livestream experience, merchandise, and the ability to browse new and upcoming artists. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Supporting Best Farming Practices to Reduce Agriculture-Related Greenhouse Gas Emissions, Ammonia Emissions

  • FuelPositive is a growth-stage company focused on developing clean energy solutions such as its onsite, containerized green ammonia production system
  • FuelPositive understands the impact of ammonia emissions on the environment and biodiversity and is supporting best farming practices that are geared toward eliminating the production, storage, and spreading of manure, a significant source of the emissions
  • The company’s system generates green ammonia, which can be injected deep into the soil, reducing the possibility of volatilization (the process through which gaseous ammonia is emitted into the atmosphere)
  • The company is working towards helping farmers solve on-farm nitrogen emissions, having already tackled fertilizer production carbon emissions
A 2022 study that sought to expose the weekly cycle of atmospheric ammonia over the main agricultural source regions in Europe – Belgium, the Netherlands, northwest Germany, Po Valley, Brittany, and the Ebro Valley –  showed that the amount of ammonia peaked during the two primary (manure) fertilization periods in spring and summer (https://ibn.fm/MR3tZ). Ammonia, NH3, is primarily used around the world as fertilizer because it is rich in nitrogen, which is essential for growing healthy crops. Manure contains ammonia, that is naturally produced. Ammonia can also be manufactured and used as mineral/synthetic fertilizer. The findings of the study are consistent with analysis by fertilizer manufacturer Yara, which observes that 94% of all ammonia emissions in the European Union (“EU”) block result from agriculture, with the remaining 6% originating from industrial applications, road transportation, and waste handling. Of the ammonia emissions generated from agriculture, livestock manure accounts for 75%, while mineral/synthetic fertilizer applications account for 22% (https://ibn.fm/sYaEu). With these emissions being linked to deleterious impacts on biodiversity – including soil acidification, direct damage to leaves and toxification of plants, and altered susceptibility to weather events – reducing the rate and levels of emissions is paramount if biodiversity is to be protected. According to a report by the Royal Society and RAND Europe (https://ibn.fm/i5qc5), ammonia emissions can, in fact, be reduced by managing the production, storage, and spreading of manure. And FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a company focused on developing clean energy solutions, suggests that emission reductions can also be realized by manufacturing green ammonia without the use of fossil fuels and injecting it deep into the ground. FuelPositive’s flagship product, an onsite, containerized green ammonia production system, uses renewable electricity to synthesize hydrogen from water and nitrogen from the air before combining the molecules in a converter to form green ammonia. In this way, and given there are no carbon emissions related to production, FuelPositive is looking to reduce the carbon emissions linked to the agriculture sector’s use of ammonia. About 80% of all grey ammonia, which is produced through a fossil-fuel energy-intensive process responsible for about 1.8% of the world’s carbon dioxide emissions, is used in the agricultural setting. In addition to reducing the carbon emissions from ammonia production, FuelPositive is looking to do more by supporting best farming practices. The company acknowledges that ammonia, even that produced by its green ammonia system, must be handled with care to prevent environmental damage. This is why farmers receive training in its safe handling and proper application. But many farmers often mismanage the production, storage, and spreading of manure, a natural source of ammonia. “Farmers spray liquid manure on the ground, which releases gaseous ammonia into the atmosphere and creates a situation where rain and runoff move a tremendous amount of highly nitrogen-intense materials (nitrous oxides or NOx) into waterways and water tables, causing significant detrimental effect (pollution) to air and water quality,” FuelPositive’s website reads (https://ibn.fm/Urjw7). Additionally, farmers’ storage practices are wanting as they often store the manure in piles and or ponds that release gaseous ammonia into the atmosphere through a process known as volatilization. FuelPositive aims to solve this problem by eliminating the carbon emissions associated with the manufacturing of ammonia used for fertilizer, and applying it through deep injection into the ground, providing the most efficient transfer of nitrogen into the soil, with the least impact from nitrous oxides. The company acknowledges the problems posed by nitrous oxides and other nitrogen-related emissions and is working with its agriculture sector advisors and scientists to address this issue and help farmers develop one implement best practices to manage and ultimately eliminate these emissions. Undeterred by the fact that nitrous oxides and other nitrogen-related emissions are not just emitted by grey or green ammonia but also by all types of nitrogen fertilizers, whether synthetic or organic, FuelPositive seeks to ultimately identify how to use its fertilizer in the least polluting way. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

With a Fresh $31 Million in Tow, EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) to Ramp RNG Supply Across Canada

  • EverGen owns and operates Western Canada’s original renewable natural gas facility and is expanding nationwide
  • EverGen already has existing offtake agreements with FortisBC, part of the nation’s largest private utility
  • EverGen recently signed a new loan agreement providing $31 million for expansion at its flagship projects in B.C.
Renewable Natural Gas, or RNG, is instrumental in meeting emissions targets by taking methane-producing organic feedstock like disposed food, sewage water, and animal waste and converting it into a carbon-neutral products, including an alternative to traditional natural gas. FortisBC Energy is a climate control steward in Western Canada, ramping supply agreements with companies such as EverGen Infrastructure (TSX.V: EVGN) (OTCQB: EVGIF) (https://ibn.fm/TIUfH) to keep up with demand from a waiting list of customers as part of a broader plan to see British Columbia reach net zero emissions by 2050. EverGen is an emerging RNG supply leader and organics processor in Canada creating a cluster of facilities to leverage both the attractive organic feedstock tip fees and long-term RNG pricing available. EverGen’s first three owned and operated facilities – Net Zero Waste Abbotsford (“NZWA”), Sea to Sky Soils (“SSS”), Fraser Valley Biogas (“FVB”) – are in southern British Columbia, with the company expanding into Alberta and Ontario in 2022 to capitalize on new opportunities in strategic jurisdictions. EverGen has long-term offtake agreements with FortisBC for the RNG produced at Net Zero Waste Abbottsford, GrowTEC, and Fraser Valley Biogas. FortisBC Energy and FortisBC, units of Newfoundland-based Fortis Inc., Canada’s biggest private utility, showed in May to have helped their customers reduce pollution by about 578,000 metric tons of carbon dioxide equivalent in 2021. That’s equivalent to a year’s worth of emissions from approximately 177,000 gasoline-powered cars. It was made possible by FortisBC increasing its RNG supply by 184% from 2020-2021. FortisBC expects to triple supply again in 2022 to be approaching 4 petajoules of RNG supply contracted to keep feeding into its pipelines. The company estimates its contracted supply is enough to replace natural gas in approximately 43,750 homes in British Columbia. EverGen has goals of its own, including estimates to generate $50-$60 million in revenue annually by achieving production of 2 million gigajoules per year of RNG. The pathway to reach these targets involves expansion projects in B.C., development projects in Alberta and Ontario, and additional target acquisitions. Thanks to a new agreement, EverGen has $31 million to move forward. Earlier this month, EverGen signed a term sheet with its existing lender, Scotiabank subsidiary Roynat Capital, and Export Development Canada for a $31 million senior term loan to support the planned upgrade and construction work at FVB ($15 million) and NZWA ($16 million). FVB, which is distinguished as the first producing RNG facility in Western Canada, combines anaerobic digestion and biogas upgrading to produce RNG, primarily by converting agricultural waste from local dairy farms. Expansion at the project is slated to begin this quarter and be completed in the first quarter of 2023, effectively doubling capacity and RNG production to approximately 120,000 gigajoules per year initially and then 160,000 gigajoules annually by mid-2023. A new offtake agreement, with existing partner FortisBC, is being finalized. NZWA is an organic waste conversion facility that primarily processes inbound organics, yard waste and biosolids for a contracted tipping fee, and produces high-quality organic compost and soils for farmers, gardeners, and developers. The capital expansion will add anaerobic digestion capabilities to produce biogas, which will then be upgraded to RNG to feed into FortisBC’s gas network under an existing 20-year off-take agreement. This project, expect to cost between $32-$35 million, has been in the works and experienced delays owning to the extensive flooding in the region last year compounded by regulatory delays related to the COVID-19 pandemic. Expectations are for groundbreaking to commence sometime in the next 12 months with a construction timeline of 6-8 months. Once complete, RNG output at NZWA is targeted at 180,000 gigajoules per year. The new production will be added to RNG totals from eastern projects. EverGen has 67% ownership of GrowTEC, an operating farm-scale biogas facility near Lethbridge, Alberta that will be expanded from 80,000 gigajoules of RNG annually to 140,000 gigajoules. The production is already under contract to supply FortisBC. That’s about 480,000 gigajoules annually from FVB, NZWA and GrowTEC. EverGen also owns 50% of a three-facility project dubbed “Project Radius” in the lower, Great Lakes region of Ontario. These three projects are thought to be constructed throughout 2023 and 2024 and be some of the larger RNG facilities in the country, with each expected to produce at least 550,000 gigajoules of RNG per year for an aggregate of approximately 1.7 million gigajoules, or nearly 2.2 million gigajoules corporate-wide for EverGen. For more information, visit the company’s website at www.EvergenInfra.com. NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

AROYA Crop Steering Expertise and Technology Provides Data-Driven Insights, Automation and Competitive Advantage for Successful Harvests

For cannabis operators, crop steering directs how their plants grow as well as their literal shape. Knowing how and when to manipulate light, climate and irrigation – the three foundational components of crop steering – is essential to balancing high yields and high quality. Why do successful growers – from small craft farmers to the largest multistate operators – use data-driven and automated crop steering solutions? Because even the slightest adjustments to any number of factors can have huge effects on grows. Data is the lifeblood of a plant growers, providing the intelligence to track how and when plants change from phase to phase and eliminate unknown variables, perfecting each run. The AROYA cultivation solution combines innovative hardware and software to deliver actionable insights from data, improving quality and yield – predictably and at scale. With data-driven insights into each aspect of harvests, operators are empowered with the knowledge to not only increase yield per square foot, but also establish and employ repeatable best practices that ensure consistent quality. Identifying and adapting to various cues – from light, climate, and irrigation – encourages plants to produce bigger flowers with higher quality as well as finish getting their DNA out into the world before they die in an evolutionary selection process known simply by “stress.” Generative stress is targeted intentional environmental pressure that encourages a plant’s behavior by focusing on reproductive parts. This not only finishes filling up space for future generations, but also removes unwanted elements like pests. In crop steering, this leads plants to produce almost double the count of bud sites. Also of note is that as every specific cultivar has its own feeding needs, automated crop steering maintains the balance between being too vegetative or too generative in terms of quality and yield. Despite the increasing use of technology across the industry, many craft and independent farmers are sticking with their tried-and-true manual methods, like physically pouring run-off into milliliter cups, taking notes, and running tests by hand. And to their credit, they’re having success. Unfortunately, failing to embrace cultivation and production technology will be their demise. In addition to competition from larger operators, many smaller outfits have gone all-in with crop steering, advanced drying and analytics. Using crop steering tech provides access to easy-to-use, comprehensive tools to collect, analyze, and understand plants on a new level. As a result, they can bring out the most sought-out features of each cultivar. The ability to consistently deliver the highest-quality products to market is the key to keeping and growing your customer base. AROYA’s Cannabis Production Platform leverages crop steering solutions and cutting-edge IoT sensor technology to help plants grow better in different environments. Combining patented telemetry systems and software turns data into insights for each phase of growth. Access to insights and analyses like rising terpenes, fluctuating THC levels, and total cannabinoids brings out the best of each strain. Hitting specific water content, moisture levels, and drying with precision brings the most out of cultivars. For large operators like STIIIZY, AROYA makes it a lot easier to manage multiple facilities and assign tasks remotely, and to know if at any time a grow is operating outside of certain thresholds. Crop steering enables scalability and growth for STIIIZY, the third best-selling brand in the United States and the number one brand in California – the largest cannabis market in the world. Analyzing historical records for each stage optimizes growth across all areas, which is how operators like STIIIZY consistently produce runs with higher yields while maintaining production levels and quality. AROYA’s technology enhances cultivation practices – which are repeatable and are implemented in every STIIIZY facility. Sean Oganesyan, Senior Vice President of Cultivation with STIIIZY, credits the company’s success to data intelligence real-time insights secured from AROYA’s Cannabis Cultivation and Production Platform, which allows him to manage multiple facilities from a single location. “The concept of sensor density is important, as more sensors deployed across our grows ensures better results and data-driven decisions that eliminate unknown variables. I don’t like variables. I dot all my i’s and cross all my t’s – that’s my military background. I need answers, I need to know exactly what’s going on, I need to be in full control of a situation, and that gave me control. That’s why I’m comfortably sitting here and talking to you today. I’m not going around somewhere in a plane or flying to some different state because somebody messed something up in my irrigation.” “The communication with the AROYA team is fluid; we both understood what we must gain from each other, and this helps STIIIZY bring good products to the market.” AROYA’s IoT sensors installed at customer facilities not only observes – but also enables digital interactions between stakeholders involved in every part of the cannabis cultivation process – from selecting nutrients to use during vegetative periods down to dietary instructions once flowerheads start forming on branches. Cultivators rely on giving plants an ideal amount of light each day; the AROYA platform provides access to this data, delivering insights on exactly what percentiles lights need to stay at with specific plants and the amount of coverage within each room, allowing growers to adjust lighting quicker using data-driven decisions. With BACnet access to AROYA with STIIIZY’s fully controlled system, Oganesyan can communicate with his controls with AROYAs sensors to make decisions for plants based on real-time data and recipes assigned to specific cultivars, adjusting things like irrigation based on EC readings in a plant’s substrate. “AROYA gives me full control of my irrigation cycles,” said Oganesyan. “I have the full analytics team behind it continuously monitoring multiple locations. All my grows are literally run through my headquarters in downtown Los Angeles.” Operators must be able to account for everything that’s going on inside their facilities, and even if you have the tightest controls, there’s still going to be variables that are just inherent to the cannabis industry, such as plant variation. Oganesyan touted AROYA’s differentiators and superior technology among the biggest selling points for selecting AROYA over other systems. “If you got a company that makes sensors and you got all the other companies buying those sensors, white labeling those sensors and want to put their name on it, I just go straight to the source.” ABOUT AROYA AROYA is a cannabis production platform that combines industry-leading hardware and software to help cultivators increase yield, scale operations, and achieve consistent quality. Based in Pullman, Washington, and a division of METER Group, Inc., AROYA optimizes and demystifies the entire cannabis production process from seed to package. For additional information, please visit AROYA.io. Third-Party Content The STBN website may contain Third-Party Content articles and other content submitted by third parties, including articles submitted through the STBN Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of STBN or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and STBN does not endorse, guarantee or make representations concerning the accuracy and completeness of any third-party content. You acknowledge that by STBN providing you with this internet portal that makes accessible to you the ability to view third party content through the STBN site, STBN does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. STBN expressly disclaims liability relating to such third-party content. STBN and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, STBN reserves the right to remove third-party content at any time in its sole discretion. By viewing this third-party content, you acknowledge that you have viewed, read fully, accepted and agreed to all terms of the Disclaimer at https://www.stockstobuynow.com/disclaimer/.

From Our Blog

Nightfood Holdings Inc. (NGTF) Is Forging the Future of Hospitality with AI-powered Automation Across Industries

September 23, 2025

Robotics and automation are no longer futuristic aspirations; they are rapidly reshaping hospitality operations today. Nightfood Holdings (OTCQB: NGTF) is pioneering this transformation with advanced AI-enabled robotic solutions designed to elevate service quality, optimize operational efficiency and enhance guest experience across the hospitality industry. Hospitality has always thrived on prompt, personalized service, but as labor […]

Rotate your device 90° to view site.